Achelois Pharmaceuticals Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Achelois Pharmaceuticals General Information

Description

Developer of nontoxic therapeutics based in San Francisco, California. The company develops technologies to reprogram T cells and turn T cell medicine into powerful medicine for solid tumors, enabling patients to inhibit tumors and eliminate pain caused by cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Achelois Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Achelois Pharmaceuticals’s complete valuation and funding history, request access »

Achelois Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Chang-Zheng Chen Ph.D Founder & Chief Executive Officer
To view Achelois Pharmaceuticals’s complete executive team members history, request access »

Achelois Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
QB3 Accelerator/Incubator 000 0000 000000 0
To view Achelois Pharmaceuticals’s complete investors history, request access »